Lv1
100 积分 2023-11-18 加入
Expert consensus on the writing of clinical testing reports of flow cytometry in graphics and text format
3个月前
已完结
2025 Update on MRD in Acute Myeloid Leukemia: A Consensus Document from the ELN-DAVID MRD Working Party
3个月前
已完结
Validation of a 12‐color flow cytometry assay for acute myeloid leukemia minimal/measurable residual disease detection
3个月前
已完结
Ferritin aggregation cell engager for CAR T avidity engineering against refractory leukemias
4个月前
已完结
Clinical progress of engineered cellular immunotherapies for autoimmunity
4个月前
已完结
Automated quantification of measurable residual disease in chronic lymphocytic leukemia using an artificial intelligence‐assisted workflow
8个月前
已完结
Performance of a novel eight‐color flow cytometry panel for measurable residual disease assessment of chronic lymphocytic leukemia
8个月前
已完结
Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL)
8个月前
已完结
Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia
8个月前
已完结
International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia
8个月前
已完结
皖公网安备34019202002308
